Published in Clin Med Insights Gastroenterol on July 14, 2014
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. J Transl Med (2015) 0.81
Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses. Drug Des Devel Ther (2015) 0.79
ROS/p38/p53/Puma signaling pathway is involved in emodin-induced apoptosis of human colorectal cancer cells. Int J Clin Exp Med (2015) 0.79
The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism. J Pharmacol Exp Ther (2015) 0.78
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary (2016) 0.78
Cancer prevention: state of the art and future prospects. J Prev Med Hyg (2015) 0.77
Polymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: Association with colorectal cancer susceptibility risk in a Malaysian population. Oncol Lett (2015) 0.77
Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells. PLoS One (2015) 0.76
Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis. Sci Rep (2016) 0.76
Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer. Front Physiol (2016) 0.76
LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. PLoS One (2015) 0.76
Nutrients Impact the Pathogenesis and Development of Colorectal Cancer. Gastrointest Tumors (2015) 0.75
Assessment and model guided cancer screening promotion by village doctors in China: a randomized controlled trial protocol. BMC Cancer (2015) 0.75
Association between obesity and local control of advanced rectal cancer after combined surgery and radiotherapy. Radiat Oncol J (2016) 0.75
Natural Agents Used in Chemoprevention of Aerodigestive and GI Cancers. Curr Pharmacol Rep (2016) 0.75
Breast Cancer Survivorship Care: Targeting a Colorectal Cancer Education Intervention. J Pers Med (2015) 0.75
Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior. Curr Colorectal Cancer Rep (2015) 0.75
High-fat Diet Accelerates Intestinal Tumorigenesis Through Disrupting Intestinal Cell Membrane Integrity. J Cancer Prev (2016) 0.75
Deregulation of the miR-16-KRAS axis promotes colorectal cancer. Sci Rep (2016) 0.75
Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients. PLoS One (2016) 0.75
Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease. Heart Fail Clin (2017) 0.75
BMI Is a Risk Factor for Colorectal Cancer Mortality. Dig Dis Sci (2017) 0.75
Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts. Oncotarget (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med (1992) 10.70
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med (2001) 8.76
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst (1999) 8.08
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.65
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 7.26
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet (2007) 7.11
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA (2006) 6.26
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA (2008) 5.94
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet (2002) 5.04
Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med (1993) 5.00
Colorectal cancer. Lancet (2005) 4.90
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology (2008) 4.68
Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet (2005) 4.65
A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol (2001) 4.61
Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med (2008) 4.55
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut (2001) 4.22
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17
Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology (2007) 4.06
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80
Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology (2007) 3.78
Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology (2007) 3.73
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr (2007) 3.66
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64
Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr (2003) 3.60
Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med (2002) 3.54
Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med (1995) 3.54
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology (2006) 3.35
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev (2007) 3.16
An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 3.14
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer (2006) 3.06
Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. J Natl Cancer Inst (2002) 3.00
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med (2007) 2.83
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76
Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg (2008) 2.75
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73
Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer (2002) 2.60
Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care (2007) 2.60
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr (2007) 2.51
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer (2006) 2.47
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med (1999) 2.42
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncol (2006) 2.32
Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen (2007) 2.30
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst (2005) 2.27
Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev (2001) 2.14
Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med (1996) 2.14
Colorectal cancer and polyps in patients aged 40 years and over who consult a GP with rectal bleeding. Fam Pract (1996) 2.13
Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer (2005) 2.11
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med (2003) 2.02
Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol (2001) 2.02
Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol (2005) 2.01
Comparative study of conventional colonoscopy and pan-colonic narrow-band imaging system in the detection of neoplastic colonic polyps: a randomized, controlled trial. J Gastroenterol (2008) 2.00
Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99
Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst (2007) 1.94
A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis (2005) 1.92
Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int J Cancer (2008) 1.91
Tobacco use and cancer causation: association by tumour type. J Intern Med (2002) 1.91
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem (2008) 1.89
Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer (2009) 1.88
The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol (2003) 1.87
Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control (2003) 1.85
Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer (2008) 1.81
Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol (2007) 1.73
First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol (2003) 1.73
Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer (2007) 1.71
Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer (2007) 1.64
Does a negative screening colonoscopy ever need to be repeated? Gut (2006) 1.61
Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst (2007) 1.57
Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat (1999) 1.57